Publications

5674 Results

Infrastructure for successful recruitment when conducting a multi-site cllinical trial: the SELECT experience

Authors
KB Anderson;ED Cook;SJ Hamilton;L Minasian;JA Hermos;JL Probstfield
Journal / Conference
NCI-ASCO Cancer Trial Accrual Symposium: Science and Solutions; poster
Year
2010
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The role of a community based organization in a large prevention trial

Authors
SJ Hamilton;ED Cook;K Anderson;JQ Sheats
Journal / Conference
NCI-ASCO Cancer Trial Accrual Symposium: Science and Solutions; poster
Year
2010
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Longer therapy and iatrogenic amenorrhea and survival in early breast cancer

Authors
S Swain;J-H Jeong;CE Geyer;JP Costantino;ER Pajon;LF Fehrenbacher;JN Atkins;J Polikoff;VG Vogel;JK Erban;P Rastogi;RB Livingston;EA Perez;EP Mamounas;SR Land;PA Ganz;N Wolmark
Journal / Conference
New England Journal of Medicine 362(22):2053-2065
Year
2010
Research Committee(s)
Breast

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group study [PMID20846714; PMC2978536]

Authors
L Randall-Whitis;BJ Monk;J Moon;R Parker;M Al-Ghazi;S Wilczynski;JP Fruehauf;M Markman;RA Burger
Journal / Conference
Gyncologic Oncology, 119(3):417-421;
Year
2010
Research Committee(s)
Gynecologic
Study Number(s)
S0013

An updated report on the pathologic complete response and survival outcome of Southwest Oncology Group (SWOG S0356): A phase II trial of oxaliplatin (OXP) plus protracted infusion 5-fluorouracil (PIFU) and external beam radiation (EBRT) prior to surgery (S) for potentially curable esophageal adenocarcinoma (EA) with molecular correlates

Authors
L Leichman;B Goldman;C Thomas;K Billingsley;C Corless;H Lenz;S Iqbal;J Benedetti;P Gold;C Blanke
Journal / Conference
American Society of Therapeutic Radiation Oncologists (ASTRO) Annual Meeting; oral
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356

Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): analysis of a Southwest Oncology Group Trial

Authors
V Sanchorawala;V Bolejack;J Crowley;A Hoering;KT Finn;S Fennessey;DC Seldin;B Barlogie
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8022); ASCO 2010 Annual Meeting; poster
Year
2010
Research Committee(s)
Myeloma
Study Number(s)
S0115

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104 [PMID20368559; PMC288173]

Authors
AH Partridge;L Archer;AB Kornblith;J Gralow;D Grenier;E Perez;AC Wolff;X Wang;H Kastrissios;D Berry;C Hudis;E Winer;M Muss
Journal / Conference
Journal of Clinical Oncology 28(14):2418-2422
Year
2010
Research Committee(s)
Breast

Does microgranular variant morphology of acute promyelocytic leukemia independently predict for a less favorable outcome compared with classical M3 APL? A joint study of North American Intergroup and PETHEMA Group [PMID20858857;PMC3031411]

Authors
M Tallman;HT Kim;P Montesinos;F Appelbaum;J de la Serna;JM Bennett;G Deben;C Bloomfield;J Gonzalez;JH Feusner;M Gonzalez;RA Larson;J Gonzalez-San Miguel;A Ogden;G Milone;JM Rowe;C Rayon;L Shepherd;C Rivas;CA Schiffer;E Vallenga;PH Wiernik;CL Willman;MA Sanz
Journal / Conference
Blood 116(25):5650-5659
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Multivitamin use is not associated with cancer recurrence or survival in patients with Stage III colon cancer: findings from CALGB 89803 [PMID20805450; PMC2954134]

Authors
K Ng;JA Meyerhardt;JA Chan;D Niedzwiecki;DR Hollis;LB Saltz;RJ Mayer;AB Benson;PL Schaefer;R Whittom;A Hantel;RM Goldberg;C Fuchs
Journal / Conference
Journal of Clinical Oncology, 28(29):4354-4363;
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy (TRT) as definitive treatment for locally advanced, unresectable esophageal cancer (Ec): a SWOG (S0414) phase II trial

Authors
CR Thomas;B Goldman;J Benedetti;H Lenz;T Beeker;JL Abbruzzese;C Blanke
Journal / Conference
ASCO 2010 Gastrointestinal Cancers Symposium, abst. #72; poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0414